Trump's drug price ultimatum sets pharma firms scrambling

A fresh ultimatum demanding "binding commitments" to lower U.S. drug prices sent pharma firms scrambling Friday.

venerdì 1 agosto 2025 New tab

14 words~1 min read

Get this delivered to your inbox, and more info about our products and services.

Other newsrooms on this story

· 8 sources

· 8 sources

A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.

cnbc.com8 mesi fa

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical…

forbes.com9 mesi fa

Pharma giants are navigating President Trump's demands to bring U.S. drug prices in line with other developed nations.

cnbc.com8 mesi fa

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo…

cnbc.com9 mesi fa

Downing Street ‘desperate’ to prevent president’s intervention over NHS rebates row

telegraph.co.uk8 mesi fa

The US president has told GSK and AstraZeneca to ‘negotiate harder with foreign freeloading nations’

telegraph.co.uk9 mesi fa